4
Changes in Ownership
Atara Biotherapeutics, Inc. Filed Acc 0001209191-17-053590
Chief Executive Officer sold 4,400 shares at an average $15.54 ($68,354)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Ciechanover Isaac E. Chief Executive Officer | 2017-09-19 | Sale | −2,200 | $15.51 | $34,122 | 435,178 | I |
| Ciechanover Isaac E. Chief Executive Officer | 2017-09-20 | Sale | −2,200 | $15.56 | $34,232 | 432,978 | I |
| Open-market sales · 4,400 sh · avg $15.54 · $68,354 | |||||||
Loading xslF345X03/doc4.xml…